Articles On Creso Pharma (ASX:CPH)

Creso Pharma’s (CPH) wholly-owned Canadian subsidiary Mernova Medicinal receives a maiden order for its Ritual Gold vaporiser products The order comes from the Weed Pool Cannabis Cooperative in Saskatchewan and consists of 40 cases of one-...

A Thai university says adding cannabis to chicken feed has positive results on meat and egg quality Aussie cannabis campaigner now a Member of the Order of Australia MGC Pharma’s CBD treatment proves effective against brain tumors   Chian...

Creso Pharma’s (CPH) subsidiary Mernova Medicinal secures an additional purchase order from the Saskatchewan province The order is valued at C$13,680 (A$15,283) and represents the first purchase order for the new Mac 1 and Grape Cream Cake...

Over the past decade, opioid-induced deaths were more likely to be due to prescription drugs than illegal drugs As scientists discover new ways to use the plant’s medicinal compounds, cannabis is seen as a possible solution to the opioid c...

Boston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving is no worries Emyria reports positive Phase 1 study results for ultra-pure CBD capsule The Boston Beer Co is launching a line of cannabis-...

Creso Pharma’s (CPH) subsidiary Halucenex Life Sciences has entered a binding supply of goods agreement with Optimi Health for EU-GMP grade psilocybin mushrooms The automatically renewing one year agreement, will see Optimi supply its whol...

ShareCafeLunch Report: 30 May, 2022 by Melissa Darmawan   Australian shares jumped to a three week high after a strong lead from Wall St. Every sector is rallying, bar utilities after news from AGL. The optimism is led by technology shares,...

The S&P/ASX 200 Index (ASX: XJO) closed slightly in the green after a wobbly old day. But three ASX microcap shares soared higher. The benchmark index closed Monday up 0.05% to 7,148.9 points. Three ASX shares that bucked this trend w...

Creso Pharma (CPH) signs a heads of agreement with tattoo aftercare specialist Dr Pickles Under the agreement, the parties will discuss a collaborative agreement to bring products from Creso’s target acquisition company, Sierra Sage Herbs...

“We’re looking forward to working closely with the Dr Pickles team on exploring multiple product and branding opportunities which have the potential to drive sales for both parties,” says Creso Pharma CEO.

Actor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wellness retreat in Byron Bay Incannex wants to buy out APIRx   It’s not surprising that Woody Harrelson loves weed – the actor was actually...

Actor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Franchise Global Health has established the first legal seedbank in Denmark Botanix nabs FDA Qualified Infection Disease Product designation for...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in the Northern Hemisphere with manufacturing deal Wednesday was 4/20 day – while it’s more of an unoff...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Ahead of Creso Pharma’s (CPH) acquisition of Sierra Sage Herbs next month, the US-based company has increased its distribution network by 20,000 points of sale The growth extends Sierra Sage Herbs’ reach into 110,000 US stores, including p...

Cann Group gets the OK in the UK for its CBD food supplements Starpharma to relaunch VIRALEZE in the UK Creso expands to LATAM Cann Group gets OK in the UK Cannabis company Cann Group (ASX:CAN) has received the green light from the UK FSA...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The S&P/ASX Emerging Companies (XEC) Index is racking about 0.3% higher on Tuesday, while the benchmark ASX 200 (XJO) rose 0.7%, buoyed by a resurgent tech sector and a strong performance from consumer discretionary companies ahead of t...

Creso Pharma’s (CPH) Canadian psychedelics company Halucenex Life Sciences is progressing the company’s first psilocybin mushroom harvest Upgrades to the Halucenex’s state-of-the-art grow room in Nova Scotia is complete, following extensiv...

The ACIC says weed consumption increased in cities and regions ROO receives USA design patent approval for its Heat Exchange Probe EMD has launched its second ultra-pure CBD capsule, the EMD-RX7   The latest Australian Criminal Intelligen...

Creso Pharma’s (CPH) subsidiary Mernova Medicinal has achieved a market share of five per cent in Nova Scotia across all product formats The company is planning for continued growth as it expects to launch its Ritual Gold oil vape in the r...

The Creso Pharma Ltd (ASX: CPH) share price is up 2% in afternoon trade. The company closed yesterday’s trading at 51 cents and its shares are currently fetching 52 cents, after hitting an intraday high of 55 cents this morning. Those gain...

Creso Pharma (CPH) organises a shipment of its cannabis lozenge products to its proposed acquisition target, Sierra Sage Herbs (SSH) A total of 35,000 CannaQIX 50 lozenge products are planned to be sent from CPH’s Swiss facility to SSH...

V-Con is Stockhead’s investing focused video conference series, bringing you expert insights, panel discussions and presentations from leading analysts, listed small caps and industry players. Global cannabis sales could hit $35 billion in...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Creso Pharma’s (CPH) subsidiary secures clinical trial authorisation from Health Canada Following the authorisation, Canadian-based psychedelics company, Halucenex Life Sciences Inc will take the final steps towards beginning its phase two...

If successful, Halucenex’s Phase 2 clinical trial is expected to give Creso Pharma access to a multibillion dollar sector. In a major development today, Creso Pharma (ASX:CPH)’s wholly-owned psychedelics subsidiary Halucenex Life has been g...

“Securing Clinical Trial Authorisation solidifies over 16 months of hard work and dedication from our team and positions Halucenex as one of very few Canadian companies with approval to commence a clinical trial utilising psychedelic substa...

Investors sold off shares in Creso Pharma after it was revealed its former chairman — who stood aside amid an ASIC investigation — helped underwrite a $5 million raising.

The Creso Pharma Ltd (ASX: CPH) share price was far from green on Friday after the ASX cannabis company broke a multi-day trading halt with news of a capital raise. Creso Pharma is raising $5 million through a placement wherein it will off...

Creso Pharma (CPH) receives firm commitments to raise $5 million through a placement to progress its US expansion The company will issue about 72.4 million new shares at a price of 6.9 cents each, representing a 10.4 per cent discount to t...

Funds raised by the placement will be used to progress a number of projects, including ongoing expansion in the US following the recent acquisition of Sierra Sage Herbs LLC and its leading Green Goo brand.

Hemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The legislation allows conditionally licensed cannabis farmers to grow weed, but they must meet certain requirements, including safe, sustainable a...

Stock Insiders is a new podcast series focussed on investing hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay Pearce Capital, Australia’s leading corporate advisory and equities trading firm.  In th...

Cannabis products group Creso Pharma appears to getting on with business, topping up its coffers to the tune of $5 million for expansion into the United States. 

“Mernova continues to progress, leveraging industry-leading cannabis quality, and we anticipate that the launch of the Ritual Gold range will provide another revenue-generating activity for the group,” CPH CEO and managing director William...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Creso Pharma (CPH) progressing well with the acquisition of Colorado-based consumer packaged goods company, Sierra Sage Herbs On February 3, Creso announced it would be entering the US market via this acquisition and is looking to purchase...

“In a short amount of time, the strong synergistic benefits resulting from the proposed acquisition are being witnessed with the launch of the new Green Goo immunity deodorant,” Creso Pharma CEO and Managing Director William Lay said.

Embattled Perth-based pharmaceutical company Creso Pharma is pinning hopes on a hemp-fuelled lozenge product that contains molecules it says could prevent COVID-19 infection.

Creso Pharma’s (CPH) new hemp-based lozenge product is in the final stages of development This product contains cannabidiolic acid (CBD-A), a chemical precursor to cannabidiol (CBD) and has shown potential therapeutic benefits Initial data...

CEO and managing director William Lay said the development of the new lozenge will become the basis for Creso to launch another strong product range.

Halucenex Life Sciences, a subsidiary of Creso Pharma (CPH), has been included on a list of companies that can provide psychedelic compounds to researchers and patients This list falls under Health Canada’s Special Access Program, which al...

NeuroScientific Biopharmaceuticals (ASX:NSB) share price jumped ~13% today to 35 cents after an update on its lead drug candidate EmtinB. The company said it has executed on the successful completion of invitro genotoxicity and plasma prote...

“We commend Health Canada’s continued progress towards providing treatment options to those needing support to combat serious or life-threatening conditions,” Halucenex president, CEO and founder Bill Fleming said.

Key points The Creso Pharma share price shot out the blocks this morning before ending the day 6% higher It has acquired a US-based company manufacturing both CBD and non-CBD products The Creso Pharma share price has fallen 57% in 12 mont...

“Our team has developed strong operations while building a robust product development capacity and expanding retail relationships exponentially. This partnership with Creso will set the stage for accelerated growth across multiple categorie...

The ASX 200 Health Index (XHJ) has fallen by 1.26% at the time of writing, compared to the broader index which is down by 0.12%. Medical device company OncoSil Medical (ASX:OSL) surged as high as 25% up today, after its device was granted a...

The acquisition of Sierra Sage Herbs will propel Creso into the US CBD market, as it pursues further US and international footprints. Cannabidiol (CBD) product sales in the US are already going gangbusters, and a new forecast predicts the m...